Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
- 30 January 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 18 (5), 297-308
- https://doi.org/10.1038/nri.2017.148
Abstract
Antibodies have been used for over a century prophylactically and, less often, therapeutically against viruses. 'Super-antibodies' — a new generation of highly potent and/or broadly cross-reactive human monoclonal antibodies — offer new opportunities for prophylaxis and therapy of viral infections. Super-antibodies are typically generated infrequently and/or in a limited number of individuals during natural infections. Isolation of these antibodies has primarily been achieved by large-scale screening for suitable donors and new single B cell approaches to human monoclonal antibody generation. Super-antibodies may offer the possibility of treating multiple viruses of a given family with a single reagent. They are also valuable templates for rational vaccine design. The great potency of super-antibodies has many advantages for practical development as therapeutic reagents. These advantages can be enhanced by a variety of antibody engineering technologies.Keywords
This publication has 159 references indexed in Scilit:
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing ActivityCell Host & Microbe, 2010
- Enhanced antibody half-life improves in vivo activityNature Biotechnology, 2010
- Monoclonal antibody-based therapies for microbial diseasesVaccine, 2009
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysNature Medicine, 2009
- A method for identification of HIV gp140 binding memory B cells in human bloodJournal of Immunological Methods, 2009
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivorNature, 2008
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningJournal of Immunological Methods, 2008
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990